Clinical Trial Update: Pilot Study on Effect Size of Non-digestible Polysaccharides (NPS) on Immunity [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 pilot trial evaluated the effect size of non-digestible polysaccharides on immune function in immunosenescence; the study is reported as compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immunosenescence

Drugs mentioned

• Non-digestible polysaccharides (NPS) (non-digestible polysaccharides)

Snippet

Sponsor: Clinical Research Center Kiel GmbH | Conditions: Immunosenescence | Phase 1, Phase 2 | Status: COMPLETED